MedTrace Logo

Evaluation of DCTclock™ as a Cognitive Assessment Aid

NCT03238001 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2018-04-03

Study results available
· View outcomes & findings →

Summary

The overall objective of this study is to demonstrate the safety and effectiveness of DCTclock as an adjunctive tool for use by clinicians to evaluate cognitive function in adults aged 55-95.

Conditions

  • Cognitive Function

Interventions

DEVICE

DCTclock

DCTclock is a quick and non-invasive test that measures cognitive function based on a computerized algorithmic analysis of the entire drawing process and output of a well-established cognitive assessment called The Clock Drawing Test (CDT).

Sponsors & Collaborators

  • Digital Cognition Technologies

    lead INDUSTRY

Principal Investigators

  • Antonia H Holway, Ph.D. · Digital Cognition Technologies, Inc.

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
55 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-11
Primary Completion
2017-11-21
Completion
2017-11-21
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03238001 on ClinicalTrials.gov